Bioreliance corp:1108045 [14-066534]
Ended Awarded Last action
- Contract number
- HHSN26100014
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77 Part of Sigma-Aldrich Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $39,085
Award facts
- Opportunity
-
- N02RC3600485 Solicitation number
- Biosafety Testing of GMP Master Cell Banks (MCB) and Retroviral Vectors for NCI Clinical Trials Award Notice · Posted Mar 7, 2013
- Contract value 100% obligated
- $39,085.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $39,085 |
About this award
This federal contract award was made by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Bioreliance Corporation, a foreign-owned, for-profit organization doing business as Bioreliance Corp De. The $39,085.34 firm fixed-price delivery order contract is for Bioreliance to provide a range of specialized testing services, including endotoxin, sterility, and general safety testing, in support of investigational new drug applications. No set-aside designation was used. Bioreliance has a long history of securing federal contracts, particularly from HHS agencies like the National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention, for its expertise in microbiological examination, bioburden testing, and safety assessments crucial for pharmaceutical and biotechnology research and development. The parent company of Bioreliance is Sigma-Aldrich Corporation, a major supplier of laboratory chemicals and related materials, which has also received federal subcontract awards.
Quick answers
Who was awarded contract HHSN26100014?
HHSN26100014 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on September 26, 2014.
How much is contract HHSN26100014 worth?
The government has obligated $39,085 on HHSN26100014.
Is contract HHSN26100014 an order under another contract?
Yes. HHSN26100014 is a delivery order under HHSN261201300026I, an indefinite delivery contract.
Was contract HHSN26100014 competed?
The extent of competition for HHSN26100014 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award